FDA Wants Comments On Generics Law, But Not Declaratory Judgments

FDA is opening a docket on implementing the changes to Waxman/Hatch made under the Medicare Rx law enacted in 2003

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet